AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 31(2), 1982, pp. 252-258
Copyright © 1982 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beacham, B. E.
Right arrow Articles by Kay, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beacham, B. E.
Right arrow Articles by Kay, H. D.

Vaccination of the African White-Tailed Rat, Mystromys Albacaudatus, with Sonicated Leishmania Braziliensis Panamensis Promastigotes*

Bruce E. Beacham, Roseann Romito AND H. David Kay
Division of Dermatology, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21202, and Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia

The usefulness of sonicated Leishmania braziliensis panamensis promastigotes for vaccination was evaluated in Mystromys albacaudatus, the African white-tailed rat. Thirty-two animals received three intradermal injections of 2 x 106 sonicated promastigotes derived from L. braziliensis panamensis at weekly intervals. One month after completion of the immunization schedule, the experimental group of animals was challenged in vivo with 2 x 106 live L. braziliensis panamensis promastogotes. At the same time, a matched group of 40 control animals was similarly challenged. Within 2 months, 35 of the 40 animals (87.5%) the control group developed ulcers, while only 14 of 32 previously vaccinated animals (43.7%) developed ulcers at the site of challenge within this same time period. The remaining 18 vaccinated animals (56.2%) remain free from ulcers 7 months after challenge. When lymphoctes from the spleens of vaccinated and control animals were challenged in vitro with antigen derived from sonicates of varing numbers of promastigotes, only cells from immunized animals responded vigorously to the antigenic challenge, a response which was not enhanced by the addition of immune antiserum to the reaction.

Accepted for publication August 27, 1981.


* Supported in part by U.S. Army Medical Research and Development Contract No. DAMD-17-79-C-9033.

In conducting the research described in this report, the investigators adhered to the Guide for the Care and Use of Laboratory Animals as promulgated by the Institute of Laboratory Animal Resources, National Academy of Science, National Research Council.




This article has been cited by other articles:


Home page
ScienceHome page
S. Giannini, M Schittini, J. Keithly, P. Warburton, C. Cantor, and L. Van der Ploeg
Karyotype analysis of Leishmania species and its use in classification and clinical diagnosis
Science, May 9, 1986; 232(4751): 762 - 765.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Society of Tropical Medicine and Hygiene.